4//SEC Filing
DOWNEY BRUCE 4
Accession 0000899243-20-027695
CIK 0001662579other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 9:27 PM ET
Size
10.6 KB
Accession
0000899243-20-027695
Insider Transaction Report
Form 4
DOWNEY BRUCE
Director
Transactions
- Conversion
Common Stock
2020-10-06+237,148→ 237,148 total - Conversion
Series A Preferred Stock
2020-10-06−2,000,000→ 0 total→ Common Stock (237,148 underlying) - Conversion
Common Stock
2020-10-06+252,394→ 489,542 total - Conversion
Series B Preferred Stock
2020-10-06−2,128,571→ 0 total→ Common Stock (252,394 underlying)
Footnotes (1)
- [F1]Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001237257
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 9:27 PM ET
- Size
- 10.6 KB